What are the regulatory thresholds for NDMA in pharmaceuticals and how do they guide the safety standards for medications?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What are the regulatory thresholds for NDMA in pharmaceuticals and how do they guide the safety standards for medications?
NDMA, a probable human carcinogen, has a regulatory threshold of 96 ng/day in pharmaceuticals, as set by the FDA. This limit ensures medications meet safety standards for long-term use.